These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 12560593)
1. Familial combined hyperlipidemia (FCHL) in children: the significance of early development of hyperapoB lipoproteinemia, obesity and aging. Kuromori Y; Okada T; Iwata F; Hara M; Noto N; Harada K J Atheroscler Thromb; 2002; 9(6):314-20. PubMed ID: 12560593 [TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension. Hunt SC; Wu LL; Hopkins PN; Stults BM; Kuida H; Ramirez ME; Lalouel JM; Williams RR Arteriosclerosis; 1989; 9(3):335-44. PubMed ID: 2497719 [TBL] [Abstract][Full Text] [Related]
4. Metabolism of apolipoprotein B in members of a family with accelerated atherosclerosis: influence of apolipoprotein E-3/E-2 pattern. Haffner SM; Kushwaha RS; Hazzard WR Metabolism; 1992 Mar; 41(3):241-5. PubMed ID: 1542261 [TBL] [Abstract][Full Text] [Related]
5. Genetic evidence from 7 families that the apolipoprotein B gene is not involved in familial combined hyperlipidemia. Rauh G; Schuster H; Müller B; Schewe S; Keller C; Wolfram G; Zöllner N Atherosclerosis; 1990 Jul; 83(1):81-7. PubMed ID: 1975179 [TBL] [Abstract][Full Text] [Related]
6. Lipoprotein and apolipoprotein abnormalities in familial combined hyperlipidemia: a 20-year prospective study. McNeely MJ; Edwards KL; Marcovina SM; Brunzell JD; Motulsky AG; Austin MA Atherosclerosis; 2001 Dec; 159(2):471-81. PubMed ID: 11730829 [TBL] [Abstract][Full Text] [Related]
7. Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia. Ayyobi AF; McGladdery SH; McNeely MJ; Austin MA; Motulsky AG; Brunzell JD Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1289-94. PubMed ID: 12750118 [TBL] [Abstract][Full Text] [Related]
8. A mouse model with features of familial combined hyperlipidemia. Masucci-Magoulas L; Goldberg IJ; Bisgaier CL; Serajuddin H; Francone OL; Breslow JL; Tall AR Science; 1997 Jan; 275(5298):391-4. PubMed ID: 8994037 [TBL] [Abstract][Full Text] [Related]
9. Replication of linkage of familial combined hyperlipidemia to chromosome 1q with additional heterogeneous effect of apolipoprotein A-I/C-III/A-IV locus. The NHLBI Family Heart Study. Coon H; Myers RH; Borecki IB; Arnett DK; Hunt SC; Province MA; Djousse L; Leppert MF Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2275-80. PubMed ID: 11031215 [TBL] [Abstract][Full Text] [Related]
10. Genetic predictors of FCHL in four large pedigrees. Influence of ApoB level major locus predicted genotype and LDL subclass phenotype. Jarvik GP; Brunzell JD; Austin MA; Krauss RM; Motulsky AG; Wijsman E Arterioscler Thromb; 1994 Nov; 14(11):1687-94. PubMed ID: 7947591 [TBL] [Abstract][Full Text] [Related]
11. Small dense LDL-cholesterol determined by a simple precipitation assay for screening familial combined hyperlipidemia. Hirano T; Nohtomi K; Sato Y; Kamata K; Ito Y Atherosclerosis; 2009 Aug; 205(2):603-7. PubMed ID: 19201411 [TBL] [Abstract][Full Text] [Related]
12. The influence of age and relative weight on the presentation of familial combined hyperlipidemia in childhood. Shamir R; Tershakovec AM; Gallagher PR; Liacouras CA; Hayman LL; Cortner JA Atherosclerosis; 1996 Mar; 121(1):85-91. PubMed ID: 8678927 [TBL] [Abstract][Full Text] [Related]
13. Increased intima-media thickness in familial combined hyperlipidemia associated with apolipoprotein B. Keulen ET; Kruijshoop M; Schaper NC; Hoeks AP; de Bruin TW Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):283-8. PubMed ID: 11834529 [TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein B as a marker of familial hyperlipoproteinemia. Sveger T; Nordborg K J Atheroscler Thromb; 2004; 11(5):286-92. PubMed ID: 15557711 [TBL] [Abstract][Full Text] [Related]
15. Carotid atherosclerosis in familial combined hyperlipidemia associated with the APOB/APOA-I ratio. Junyent M; Zambón D; Gilabert R; Cofán M; Núñez I; Ros E Atherosclerosis; 2008 Apr; 197(2):740-6. PubMed ID: 17698072 [TBL] [Abstract][Full Text] [Related]
16. Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions. Ellis KL; Pang J; Chan DC; Hooper AJ; Bell DA; Burnett JR; Watts GF J Clin Lipidol; 2016; 10(6):1329-1337.e3. PubMed ID: 27919349 [TBL] [Abstract][Full Text] [Related]
17. Associations of apolipoprotein B with pulse pressure and glucose in Chinese families with familial combined hyperlipidemia. Pei WD; Sun YH; Liu Q; Zheng WY; Zhang J; Zhang CY; Gong J; Hopkins PN; Hui RT; Liu LS; Yang YJ Int J Cardiol; 2007 Feb; 115(3):293-6. PubMed ID: 16797745 [TBL] [Abstract][Full Text] [Related]
18. [Apolipoprotein B is associated with metabolic syndrome in Chinese pedigrees with familial hyperlipidemia]. Pei WD; Sun YH; Rou WJ; Zu Q; Li Y; Zhang CY; Dai J; Jia YH; Lu ZL; Wu XG; Liu LS; Hui RT Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):313-7. PubMed ID: 15854507 [TBL] [Abstract][Full Text] [Related]
19. Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia. Austin MA; Brunzell JD; Fitch WL; Krauss RM Arteriosclerosis; 1990; 10(4):520-30. PubMed ID: 2369363 [TBL] [Abstract][Full Text] [Related]
20. Genotype at a major locus with large effects on apolipoprotein B levels predicts familial combined hyperlipidemia. Jarvik GP; Beaty TH; Gallagher PR; Coates PM; Cortner JA Genet Epidemiol; 1993; 10(4):257-70. PubMed ID: 8224806 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]